Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

TSX:CJR-B - Toronto Stock Exchange - CA2208741017 - Common Stock - Currency: CAD

0.1  +0.01 (+5.26%)

Fundamental Rating

2

Overall CJR-B gets a fundamental rating of 2 out of 10. We evaluated CJR-B against 14 industry peers in the Media industry. Both the profitability and financial health of CJR-B have multiple concerns. CJR-B does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CJR-B had negative earnings in the past year.
CJR-B had a positive operating cash flow in the past year.
CJR-B had negative earnings in 4 of the past 5 years.
Each year in the past 5 years CJR-B had a positive operating cash flow.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a Return On Assets value of -47.42%, CJR-B is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 6.43%, CJR-B is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CJR-B is significantly below the industry average of 35.46%.
Industry RankSector Rank
ROA -47.42%
ROE N/A
ROIC 6.43%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

CJR-B has a Operating Margin of 9.12%. This is in the better half of the industry: CJR-B outperforms 78.57% of its industry peers.
In the last couple of years the Operating Margin of CJR-B has declined.
CJR-B's Gross Margin of 53.83% is amongst the best of the industry. CJR-B outperforms 85.71% of its industry peers.
In the last couple of years the Gross Margin of CJR-B has declined.
Industry RankSector Rank
OM 9.12%
PM (TTM) N/A
GM 53.83%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CJR-B is creating value.
Compared to 1 year ago, CJR-B has about the same amount of shares outstanding.
Compared to 5 years ago, CJR-B has less shares outstanding
The debt/assets ratio for CJR-B is higher compared to a year ago.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CJR-B has an Altman-Z score of -1.48. This is a bad value and indicates that CJR-B is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.48, CJR-B perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of CJR-B is 12.33, which is on the high side as it means it would take CJR-B, 12.33 years of fcf income to pay off all of its debts.
CJR-B has a Debt to FCF ratio (12.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.33
Altman-Z -1.48
ROIC/WACC1.55
WACC4.14%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.65 indicates that CJR-B may have some problems paying its short term obligations.
CJR-B has a worse Current ratio (0.65) than 85.71% of its industry peers.
A Quick Ratio of 0.65 indicates that CJR-B may have some problems paying its short term obligations.
The Quick ratio of CJR-B (0.65) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -186.36% in the last year.
CJR-B shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -43.12% yearly.
Looking at the last year, CJR-B shows a very negative growth in Revenue. The Revenue has decreased by -14.72% in the last year.
CJR-B shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.52% yearly.
EPS 1Y (TTM)-186.36%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-600%
Revenue 1Y (TTM)-14.72%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-9.74%

3.2 Future

CJR-B is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.99% yearly.
The Revenue is expected to decrease by -5.42% on average over the next years.
EPS Next Y-573.8%
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue Next Year-11.4%
Revenue Next 2Y-8.68%
Revenue Next 3Y-5.42%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CJR-B. In the last year negative earnings were reported.
Also next year CJR-B is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CJR-B is valued cheaper than 92.86% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CJR-B indicates a rather cheap valuation: CJR-B is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.23
EV/EBITDA 1.36
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

CJR-B's earnings are expected to decrease with -25.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%

0

5. Dividend

5.1 Amount

No dividends for CJR-B!.
Industry RankSector Rank
Dividend Yield N/A

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (5/1/2025, 7:00:00 PM)

0.1

+0.01 (+5.26%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-11 2025-04-11/bmo
Earnings (Next)07-14 2025-07-14
Inst Owners4.14%
Inst Owner ChangeN/A
Ins Owners3.57%
Ins Owner ChangeN/A
Market Cap19.61M
Analysts43.08
Price Target0.09 (-10%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.25%
Min EPS beat(2)-75.76%
Max EPS beat(2)33.26%
EPS beat(4)2
Avg EPS beat(4)-55.69%
Min EPS beat(4)-251.7%
Max EPS beat(4)71.44%
EPS beat(8)5
Avg EPS beat(8)-5.39%
EPS beat(12)5
Avg EPS beat(12)-171.05%
EPS beat(16)8
Avg EPS beat(16)-128.06%
Revenue beat(2)0
Avg Revenue beat(2)-3.31%
Min Revenue beat(2)-3.66%
Max Revenue beat(2)-2.96%
Revenue beat(4)0
Avg Revenue beat(4)-5.28%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-2.96%
Revenue beat(8)0
Avg Revenue beat(8)-4.35%
Revenue beat(12)1
Avg Revenue beat(12)-3.71%
Revenue beat(16)1
Avg Revenue beat(16)-3.28%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-140%
EPS NQ rev (3m)-580%
EPS NY rev (1m)-199.99%
EPS NY rev (3m)-436.63%
Revenue NQ rev (1m)-1.89%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.23
P/OCF 0.2
P/B N/A
P/tB N/A
EV/EBITDA 1.36
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.43
FCFY432.69%
OCF(TTM)0.51
OCFY505.08%
SpS6.11
BVpS-2.18
TBVpS-7.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.42%
ROE N/A
ROCE 8.92%
ROIC 6.43%
ROICexc 6.95%
ROICexgc 277.86%
OM 9.12%
PM (TTM) N/A
GM 53.83%
FCFM 7.08%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.33
Debt/EBITDA 1.45
Cap/Depr 2.33%
Cap/Sales 1.18%
Interest Coverage 1.65
Cash Conversion 13.8%
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z -1.48
F-Score4
WACC4.14%
ROIC/WACC1.55
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.36%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-600%
EPS Next Y-573.8%
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.72%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-9.74%
Revenue Next Year-11.4%
Revenue Next 2Y-8.68%
Revenue Next 3Y-5.42%
Revenue Next 5YN/A
EBIT growth 1Y-40.38%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year7.07%
EBIT Next 3Y8.74%
EBIT Next 5YN/A
FCF growth 1Y-31.59%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-29.84%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%